We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

CCC Project- Acute Coronary Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02306616
Recruitment Status : Completed
First Posted : December 3, 2014
Last Update Posted : January 27, 2021
American Heart Association
Chinese Society of Cardiology
Information provided by (Responsible Party):
Dong ZHAO, Beijing Institute of Heart, Lung and Blood Vessel Diseases

Brief Summary:
To develop and implement quality improvement programs for the treatment of acute coronary syndrome (ACS) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of acute coronary syndrome.

Condition or disease
Acute Coronary Syndrome

Layout table for study information
Study Type : Observational
Actual Enrollment : 124363 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome
Study Start Date : November 2014
Actual Primary Completion Date : December 2020
Actual Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. The overall composite of 11 performance measures for ACS care [ Time Frame: Duration of hospital stay, an expected average of 1 week ]

    Performance measures for ACS care including:

    1. Proportion of patients received aspirin at arrival
    2. Proportion of patients received fibrinolytic therapy within 30 mins (STEMI)
    3. Proportion of patients received primary percutaneous coronary intervention within 90 mins (STEMI)
    4. Proportion of patients received reperfusion therapy (STEMI)
    5. Proportion of patients with aspirin prescribed at discharge
    6. Proportion of patients with clopidogrel or other P2Y12 inhibitors prescribed at discharge
    7. Proportion of patients with beta-blocker prescribed at discharge
    8. Proportion of patients with statin prescribed at discharge
    9. Proportion of patients received evaluation of left ventricular systolic function
    10. Proportion of left ventricular systolic dysfunction patients with ACEI or ARB prescribed at discharge
    11. Proportion of patients received smoking cessation advice/ counseling

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Hospitalized patients with acute coronary syndrome

Inclusion Criteria:

Hospitalized patients with discharge diagnosis as acute coronary syndrome (including STEMI, NSTEMI and UAP) in 150 tertiary and 100 secondary hospitals.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02306616

Layout table for location information
Beijing An Zhen Hospital
Beijing, China
Sponsors and Collaborators
Beijing Institute of Heart, Lung and Blood Vessel Diseases
American Heart Association
Chinese Society of Cardiology
Layout table for investigator information
Principal Investigator: Dong Zhao, Ph. D Beijing Institute of Heart, Lung and Blood Vessel Diseases
Additional Information:
Publications of Results:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Dong ZHAO, Principal Investigator, Beijing Institute of Heart, Lung and Blood Vessel Diseases
ClinicalTrials.gov Identifier: NCT02306616    
Other Study ID Numbers: CCC-ACS-2014
First Posted: December 3, 2014    Key Record Dates
Last Update Posted: January 27, 2021
Last Verified: January 2021
Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Coronary Syndrome
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases